Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Myocilin Blocking Peptide (AC1352)
Cat.#: ACPP-1352
Specifications
Despition Myocilin Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1084 Recombinant Human Autotaxin Protein (Functional) (AC1084) 10 µg inquiry ACPP-1506 Human NDE1 Protein (AC1506) 5 µg inquiry ACPP-1100 Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) 50 µg inquiry ACPP-1755 Human PDGFD Protein (AC1755) 5 µg inquiry ACPP-1294 DCC Blocking Peptide (AC1294) 250 µg inquiry ACPP-1823 Human SOX2 Protein, TAT (AC1823) 5 µg inquiry ACPP-1778 Human HSD17B10 Protein (AC1778) 2 µg inquiry ACPP-1306 FGFR2 Blocking Peptide (AC1306) 250 µg inquiry ACPP-1114 Recombinant Human NCAM1 Protein (6×His Tag) (AC1114) 50 µg inquiry ACPP-1293 TORC2 Blocking Peptide (AC1293) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket